S. 2540 (119th)Bill Overview

Comprehensive Addiction and Recovery Justice Grant Reauthorization Act

Crime and Law Enforcement|Crime and Law Enforcement
Cosponsors
Support
Bipartisan
Introduced
Jul 30, 2025
Discussions
Bill Text
Current stageCommittee

Read twice and referred to the Committee on the Judiciary.

Introduced
Committee
Floor
President
Law
Congressional Activities
01 · The brief
Plain-English summaryWhat this bill actually does

This bill amends the Omnibus Crime Control and Safe Streets Act of 1968 to reauthorize the Department of Justice’s Comprehensive Opioid Abuse (Comprehensive Addiction and Recovery Justice) Grant Program by updating the statutory authorization period to cover fiscal years 2026 through 2030. The text edits replace an earlier authorization reference (including specific FY2017–2018 amounts and an authorization through 2019–2023) with a new authorization span that includes 2026–2030.

Why people may split

Extent of federal spending and whether appropriations will follow: liberals assume need for robust funding; conservatives worry about unfunded mandates and prefer strict accountability.

Watch point

Relative to its intended legislative type, this bill is a narrow statutory amendment that clearly integrates with existing law and unambiguously changes the authorization period for an existing DOJ grant program.

This bill amends the Omnibus Crime Control and Safe Streets Act of 1968 to reauthorize the Department of Justice’s Comprehensive Opioid Abuse (Comprehensive Addiction and Recovery Justice) Grant Program by updating the statutory authorization period to cover fiscal years 2026 through 2030.

The text edits replace an earlier authorization reference (including specific FY2017–2018 amounts and an authorization through 2019–2023) with a new authorization span that includes 2026–2030.

The bill does not itself appropriate new funds; it changes the statutory authorized period for the grant program.

Passage70/100

Based solely on content, this is a routine, narrow reauthorization addressing opioid treatment and recovery grants—an area that tends to receive bipartisan support and is administratively straightforward. The main limitation is that authorizations require appropriations to provide funding, and the bill does not specify amounts or offsets, which introduces fiscal considerations that could slow or block implementation.

CredibilityAligned

Relative to its intended legislative type, this bill is a narrow statutory amendment that clearly integrates with existing law and unambiguously changes the authorization period for an existing DOJ grant program. It is concise and technically framed as a reauthorization.

Contention28/100

Extent of federal spending and whether appropriations will follow: liberals assume need for robust funding; conservatives worry about unfunded mandates and prefer strict accountability.

02 · What it does

Who stands to gain, and who may push back.

Likely benefits vs burdens50% / 50%
Local governments · Federal agenciesFederal agencies

These are examples from the analysis, not a ranked list of the most-affected groups.

Likely helped
  • Local governmentsMaintains a predictable federal funding vehicle for grants that support local law enforcement, treatment, prevention, a…
  • Local governmentsMay preserve or support jobs in public health, substance use treatment, behavioral health services, and criminal justic…
  • Federal agenciesContinues federal–state partnership and coordination mechanisms for addressing opioid-related overdoses and related cri…
Likely burdened
  • Federal agenciesAuthorizes additional federal spending authority without specifying offsets; critics may argue it increases long‑term f…
  • Potential burdenIf program implementation emphasizes criminal justice responses rather than harm‑reduction or voluntary treatment model…
  • Potential burdenThe extension alone does not guarantee improved outcomes; critics may note that reauthorization without changes to prog…
03 · Why people split

Why the argument around this bill splits.

Extent of federal spending and whether appropriations will follow: liberals assume need for robust funding; conservatives worry about unfunded mandates and prefer strict accountability.
Progressive85%

A mainstream liberal would likely view this as a broadly positive, pragmatic step to continue federal support for treatment, recovery, and justice-related responses to opioid and substance use disorders.

They would welcome reauthorization of a DOJ grant program that funds prevention, treatment access, and recovery services, while noting the text provided does not specify funding levels or new policy improvements.

They would emphasize the need for the program to center equity and expand community-based treatment rather than criminalization.

Leans supportive
Centrist80%

A centrist would see this as a routine, pragmatic reauthorization of a federal grant program addressing a widely acknowledged public health and public safety problem.

They would appreciate keeping a federal funding mechanism available for states and localities while noting the amendment is narrowly procedural — it extends authorization years without detailing appropriations, program design, or new reforms.

Their support would hinge on assurances of fiscal responsibility, oversight, and evidence that the program funds effective interventions.

Leans supportive
Conservative55%

A mainstream conservative would likely view the bill as a modest, possibly acceptable reauthorization so long as it does not expand federal overreach or create large new unfunded obligations.

They may support continued federal assistance for opioid treatment and recovery when tied to efforts that reduce crime and promote accountability, but be wary of open-ended federal spending and prefer state/local control.

Some conservatives would want assurances that grants fund treatment and justice reforms that emphasize personal responsibility and public safety rather than broad expansions of entitlement-style programs.

Split reaction
04 · Can it pass?

The path through Congress.

Introduced

Reached or meaningfully advanced

Committee

Reached or meaningfully advanced

Floor

Still ahead

President

Still ahead

Law

Still ahead

Passage likelihood70/100

Based solely on content, this is a routine, narrow reauthorization addressing opioid treatment and recovery grants—an area that tends to receive bipartisan support and is administratively straightforward. The main limitation is that authorizations require appropriations to provide funding, and the bill does not specify amounts or offsets, which introduces fiscal considerations that could slow or block implementation.

Scope and complexity
24%
Scopenarrow
24%
Complexitylow
Why this could stall
  • The bill text does not state specific authorized funding levels for the new FY2026–2030 period, so the fiscal magnitude and appropriations demands are unclear.
  • Authorization does not guarantee appropriation; passage and implementation depend on later appropriations decisions and budgetary negotiations.
05 · Recent votes

Recent votes on the bill.

No vote history yet

The bill has not accumulated any surfaced votes yet.

06 · Go deeper

Go deeper than the headline read.

Included on this page

Extent of federal spending and whether appropriations will follow: liberals assume need for robust funding; conservatives worry about unfun…

Based solely on content, this is a routine, narrow reauthorization addressing opioid treatment and recovery grants—an area that tends to re…

Unlocked analysis

Relative to its intended legislative type, this bill is a narrow statutory amendment that clearly integrates with existing law and unambiguously changes the authorization period for an existing DOJ grant program. It is…

Go beyond the headline summary with full stakeholder mapping, legislative design analysis, passage barriers, and lens-by-lens tradeoff breakdowns.

Perspective breakdownsPassage barriersLegislative design reviewStakeholder impact map
Open full analysis